BIOMAT Database Logo BIOMAT Database Logo

How reliable are enteric-coated aspirin preparations? 1965

R L Clark, and L Lasagna

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic
D013608 Tablets, Enteric-Coated Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed) Enteric-Coated Tablets,Tablets, Enteric Coated

Related Publications

R L Clark, and L Lasagna
Enteric coated aspirin.
April 2007, The American journal of medicine,
R L Clark, and L Lasagna
Enteric-coated aspirin.
February 1983, Southern medical journal,
R L Clark, and L Lasagna
Lack of Bioequivalence Among Low-dose, Enteric-coated Aspirin Preparations.
June 2018, Clinical pharmacology and therapeutics,
R L Clark, and L Lasagna
Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
June 1986, International journal of clinical pharmacology, therapy, and toxicology,
R L Clark, and L Lasagna
Enteric coated aspirin today.
October 1985, The Journal of rheumatology,
R L Clark, and L Lasagna
Absorption of enteric-coated aspirin.
January 1983, JAMA,
R L Clark, and L Lasagna
Poisoning with enteric-coated aspirin.
July 1981, Lancet (London, England),
R L Clark, and L Lasagna
The value of enteric-coated aspirin.
January 1950, The New England journal of medicine,
R L Clark, and L Lasagna
Self-poisoning with enteric-coated aspirin.
December 1983, American journal of clinical pathology,
R L Clark, and L Lasagna
Gastric safety and enteric-coated aspirin.
February 1997, Lancet (London, England),
Copied contents to your clipboard!